help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on September 15, 2005, doi:10.1165/rcmb.2005-0182OC

Am. J. Respir. Cell Mol. Biol., Volume 33, Number 6, December 2005, 582-588

A more recent version of this article appeared on December 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0182OCv1
33/6/582    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munson, D. A
Right arrow Articles by Ischiropoulos, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munson, D. A
Right arrow Articles by Ischiropoulos, H.

Submitted on May 13, 2005
Revised on September 14, 2005

Pulmonary and Systemic Nitric Oxide Metabolites in a Baboon Model of Neonatal Chronic Lung Disease

David A Munson1, Peter H Grubb2, Jay D Kerecman2, Donald C McCurnin3, Bradley A Yoder4, Philip W Shaul3, and Harry Ischiropoulos1*

1 Department of Biochemistry and Biophysics, The University of Pennsylvania, Children's Hospital of Philadelphia, The Joseph Stokes Jr. Research Institute, Philadelphia, PA, USA, 2 San Antonio Military Pediatric Center, San Antonio, TX, USA, 3 Department of Pediatrics, University of Texas Health Science Center, San Antonio, TX, USA, 4 Department of Pathology, University of Texas Health Science Center and the Southwest Foundation for Biomedical Research, TX, USA

* To whom correspondence should be addressed. E-mail: ischirop{at}mail.med.upenn.edu.

Herein we report on developmental changes of pulmonary and systemic nitric oxide metabolites in a baboon model of chronic lung disease with or without exposure to inhaled nitric oxide. The plasma levels of nitrite and nitrate, staining for S-nitrosothiols and 3-nitrotyrosine in the large airways increased between 125 days and 140 days of gestation (term 185 days) in animals developing in utero. The developmental increase in nitric oxide-mediated protein modifications was not interrupted by delivery at 125 days of gestation and mechanical ventilation for 14 days, while plasma nitrite and nitrate levels increased in this model. Exposure to inhaled nitric oxide resulted in a further increase in plasma nitrite and nitrate and an increase in plasma S-nitrosothiols, without altering lung NO synthase expression. These data demonstrate a developmental progression in levels of pulmonary nitric oxide metabolites that parallel known maturational increases in total NOS activity in the lung. Interestingly, despite known suppression of total pulmonary NOS activity in the chronic lung disease model, pulmonary and systemic nitric oxide metabolite levels are higher than in the developmental controls. Thus, a deficiency in nitric oxide production and biological function in the premature baboon was not apparent by the detection and quantification of these surrogate markers of nitric oxide production.




This article has been cited by other articles:


Home page
PediatricsHome page
P. L. Ballard, W. E. Truog, J. D. Merrill, A. Gow, M. Posencheg, S. G. Golombek, L. A. Parton, X. Luan, A. Cnaan, and R. A. Ballard
Plasma Biomarkers of Oxidative Stress: Relationship to Lung Disease and Inhaled Nitric Oxide Therapy in Premature Infants
Pediatrics, March 1, 2008; 121(3): 555 - 561.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2005 American Thoracic Society.